A phase I/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy (HAART) in HIV-positive patients with cancer: AIDS Malignancy Consortium Trial AMC 061

BACKGROUND: Treatment of non-AIDS defining cancers (NADCs) may be complicated by drug interactions between highly active antiretroviral therapy (HAART) and chemotherapy. This trial is the first by the AIDS Malignancy Consortium assessing targeted therapies and HAART in HIV+ cancer patients (Clinical...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rudek, Michelle A, Moore, Page C., Mitsuyasu, Ronald T., Dezube, Bruce J., Aboulafia, David, Gerecitano, John, Sullivan, Ryan, Cianfrocca, Mary E., Henry, David H., Ratner, Lee, Haigentz, Missak, Dowlati, Afshin, Little, Richard F., Ivy, S. Percy, Deeken, John F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4038645/
https://ncbi.nlm.nih.gov/pubmed/24474568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28554
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados